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Summary
The successful USA300 Community-Associated Methicillin-Resistant Staphylococcus aureus
(CA-MRSA) lineage predominantly causes skin and soft tissue infections (SSTIs) and is highly
associated with carriage of the Arginine Catabolic Mobile Element (ACME). However, the
contribution of ACME to USA300 fitness during SSTIs remains incompletely understood. We
show that the constitutive ACME-encoded arginine-deiminase system (Arc) allows USA300 to
thrive in acidic environments that mimic human skin. Consequently, ACME-Arc drives excessive
production of host polyamines, compounds uniquely toxic to S. aureus. To mitigate this, ACME
also encodes SpeG, a polyamine-resistance enzyme that is essential for combating excess host
polyamines in a murine SSTI model. Inhibiting host polyamine production not only restored
ΔspeG persistence within infected wounds but also severely altered the host healing process,
implying that polyamines play integral roles in coordinating the wound-healing response.
Together, these data underscore the functional modularity of ACME and its contribution to the
success of USA300 CA-MRSA.
Introduction
Infections caused by Methicillin-Resistant Staphylococcus aureus (MRSA) have plagued
healthcare settings for years (DeLeo et al., 2010). In the last two decades however, MRSA
isolates have shifted from being exclusively hospital associated (HAMRSA) to the most
common cause of community associated (CA-MRSA) skin and soft tissue infections (SSTIs)
(Talan et al., 2011). The dominant CA-MRSA clones in the US belong to the pulsed-field
type USA300 (McDougal et al., 2003). USA300 can account for 98% of MRSA SSTIs
presenting to emergency rooms and has spread into healthcare settings causing the majority
of nosocomial infections (Popovich et al., 2008; Talan et al., 2011). The increased
prevalence of USA300 disease is partially explained by the overproduction of toxins
resulting in hypervirulence in animal models (Bubeck Wardenburg et al., 2007; Li et al.,
2009; Montgomery et al., 2008). However, hypervirulence alone cannot account for the
dominance of USA300 CA-MRSA (Thurlow et al., 2012). For instance, the rapid
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replacement of other CA-MRSA lineages (e.g. USA400) in North America by USA300
clones entailed highly efficient transmission, a trait that cannot be fully explained by
hypervirulence. Currently, our understanding of the factors that contribute to the remarkable
success of USA300 clones is incomplete.
USA300 pathogenicity requires the overexpression of major virulence factors common
among all S. aureus including Agr-regulated toxins (Bubeck Wardenburg et al., 2007;
Kobayashi et al., 2011; Li et al., 2010; Montgomery et al., 2010). The exact mechanism
behind the overproduction of these virulence traits in USA300 clones is not clear, but it has
recently been demonstrated that other non-USA300 lineages also exhibit toxin
overproduction (e.g. USA500) (Li et al., 2010). Additionally, USA300 isolates produce the
Panton-Valentine Leukotoxin (PVL), but the exact contribution of PVL to USA300 disease
is still unclear (Bubeck Wardenburg et al., 2008; Kobayashi et al., 2011; Lipinska et al.,
2011; Loffler et al., 2010). Finally, most USA300 S. aureus from North America harbor the
Arginine Catabolic Mobile Element (ACME) (Diep et al., 2008; Reyes et al., 2009). In
contrast, ACME is only found in a rare subset of MRSA clones from Northern Europe and
Japan (Bartels et al., 2011; Ellington et al., 2008; Shore et al., 2011; Urushibara et al., 2012).
However, USA300 ΔACME mutants have only modest virulence defects in rabbit
endocarditis, and no measurable phenotypes in murine sepsis or SSTIs (Diep et al., 2008;
Montgomery et al., 2009). Thus, it is still unclear how ACME and other USA300 features
act together to contribute to the emergence of epidemic CA-MRSA in North America.
SSTIs are the most common clinical presentations associated with USA300 CAMRSA
disease (DeLeo et al., 2010; Talan et al., 2011). The surface of the skin is a harsh acidic
environment given the low pH of sweat and scarce nutrients (Di Meglio et al., 2011).
Furthermore, the epidermis is immunologically active and serves as a formidable barrier to
invading pathogens. The dermal layer also hosts a variety of immune cells which respond
robustly to cytokines, chemokines and available nutrients (Miller and Cho, 2011). Arginine
is a prominent nutrient mediator in the cutaneous immune response as it is involved in both
initial inflammation and subsequent resolution. Initially, infected tissue is inflamed and
marked by cytokines such as IL-1, INF-γ and TNF-α with host arginine being primarily
consumed by iNOS to generate nitric oxide (NO·) (Gantwerker and Hom, 2012; Satriano,
2004). Once signals from damaged tissue outweigh inflammatory cues, the host response
shifts towards the synthesis of anti-inflammatory cytokines including IL-4, IL-10, IL-13 and
TGF-β (Gantwerker and Hom, 2012). During this resolution phase, Arginase-1 (ARG-1)
redirects arginine towards the production of ornithine (Satriano, 2004), which can be
converted to a group of compounds collectively referred to as polyamines (i.e. putrescine
(Put), spermidine (Spd) and spermine (Spd)) (Cohen, 2000).
Polyamines are critical for proper wound healing as they are anti-inflammatory and promote
cell proliferation and tissue regeneration (Cohen, 2000; Curran et al., 2006). Polyamines
were thought to be ubiquitous among all living organisms, however S. aureus lacks
polyamine synthesis and is rapidly killed by physiological Spm concentrations (Joshi et al.,
2011). The only exceptions to S. aureus polyamine-sensitivity were USA300 isolates (e.g.
LAC and SF8300), which express an ACME-encoded Spm/Spd acetyltransferase (SpeG)
that accounts for full polyamine-resistance. Thus, polyamine resistance is a unique
characteristic that distinguishes USA300 from other S. aureus. However, whether SpeG
contributes to virulence and/or persistence of USA300 S. aureus has never been established.
Here we demonstrate that the modular ACME island directly contributes to persistence in
environments mimicking conditions found on human skin and within cutaneous abscesses.
The constitutive arginine deiminase system (Arc) encoded on ACME allows USA300 to
thrive in acidic environments similar to that of human sweat. However, once USA300 S.
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aureus penetrates the epidermis, ACME-Arc drives excessive host polyamine synthesis
necessitating SpeG. Thus, the acquisition of ACME allows USA300 to combat the high
levels organic acids and polyamines in skin thereby contributing to the dominance of
USA300 in SSTIs.
Results
Constitutive USA300 ACME Arc promotes survival in acidic environments
The pH of skin is low (~5.0) given the high abundance of lactic acid in sweat (Harvey et al.,
2010). It has been proposed that ammonia produced by the ACME-encoded arginine
deiminase system (ACME-Arc) may contribute to acid tolerance during skin colonization
(Figure 1A) (Diep et al., 2006). Cultivating USA300 in defined medium buffered at pH 5.0
containing physiological levels of arginine and lactic acid resulted in 2-log growth over 24 h
(Figures 1B and S1). In contrast, isogenic ΔACME and ΔArc mutants exhibited no
significant growth under these conditions. Additionally, all similarly cultured non-USA300
S. aureus strains were unable to grow in acidic media (Figures 1B and S1). All strains grew
equally well in defined medium buffered at or above pH 6.0 (data not shown). A plasmid
harboring the ACME Arc gene cluster conferred full acid tolerance to S. aureus strain
Newman (Figure 1B). Thus, the presence of ACME-Arc is necessary and sufficient for
growth in acidic skin-like environments. These results imply that the ACME-Arc system is
expressed in aerated media, a condition known to repress the Arc system from the core
genome of all S. aureus (Harvey et al., 2010; Makhlin et al., 2007). In contrast to
chromosomal Arc, ACME-Arc was constitutively expressed regardless of the presence of
glucose and/or oxygen (Figure 1C). Thus, USA300 clones thrive in lactic acid-rich
environments given the ammonia production derived from constitutive ACME-Arc
expression.
S. aureus resists host inflammation but is effectively cleared within post-inflammatory
abscesses
Host arginine feeds multiple pathways during a typical immune response (Figure 2A).
Initially, infected tissue is inflamed and macrophages primarily consume arginine via iNOS
to generate NO· (Gantwerker and Hom, 2012; Satriano, 2004). Over time, the host shifts
away from NO· production and macrophages redirect arginine via ARG-1, towards the
production of ornithine, which can be further converted to polyamines (Figure 2A)
(Gantwerker and Hom, 2012; Satriano, 2004). In the murine SSTI model, subcutaneously
injected USA300 S. aureus replicate and cause dermonecrotic lesions within 24 to 48 h
(Figure 2B). Histological staining of S. aureus skin abscesses sections revealed high levels
of infiltrating granulocytes surrounding central regions of necrosis (Figures 2D and S2).
Infections typically resolve within two weeks as the contracting dermonecrotic lesion is
encased within a fibrotic wall primarily composed of fibronectin and collagen.
Immunohistological staining of S. aureus abscesses revealed an early inflammatory
signature with high iNOS expression (Figure 2E). Eventually, the host response shifts to an
anti-inflammatory phase with enhanced ARG-1 expression and little detectable iNOS
(Figures 2E and 2F). The immunohistology was quantitatively validated using flow
cytometry (Figure 2G). At day-7, abscesses possessed significant numbers of both ARG-1+
and iNOS+ macrophages, but by day 12, abscesses were virtually devoid of iNOS+ cells and
were highly enriched for Arg-1 (Figure 2G). Thus, only early abscesses are replete with
NO·, an innate immune effector to which S. aureus is inherently resistant (Hochgrafe et al.,
2008; Richardson et al., 2008). Accordingly, very little loss of bacterial viability is observed
within the first week following S. aureus inoculation (Figure 2C). In contrast, NO·-sensitive
Staphylococcus epidermidis and Enterococcus faecalis are rapidly cleared within inflamed
abscesses underscoring their comparative sensitivity to inflammation. However, as the
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healing process unfolds, S. aureus likely encounters less inflammation and is increasingly
exposed to the post-inflammatory phase, which is notably efficient at clearing S. aureus.
These data imply that the unique resistance of S. aureus to oxidative/nitrosative stresses
enables persistence within early abscesses, but unidentified effectors expressed during the
resolution phase exert potent anti-staphylococcal activity. Additionally, non-USA300 clones
are particularly susceptible to this post-inflammatory killing mechanism in that MSSA strain
Newman was significantly less viable than USA300 at day 12 (17-fold fewer viable cfu, p ≤
0.01, Students t-test) (Figure 2C).
Host polyamines contribute to post-inflammatory clearing of S. aureus
SpeG-expressing USA300 clones are the only polyamine-resistant S. aureus strains known
(Joshi et al., 2011). USA300 ΔspeG begins to exhibit significantly less viability at day 7
when high-level ARG-1 expression is first observed (Figures 2F and 3A). By day 12, ΔspeG
is 23-fold less abundant than WT in healing abscesses (Figure 3A). Repairing the ΔspeG
allele fully restored WT persistence and speG was also required for full virulence in another
USA300 background, LAC (Figure 3B). Moreover, abscesses were on average 6-fold larger
in mice infected with WT LAC versus isogenic ΔspeG (data not shown, p < 0.05, Mann-
Whitney). Thus, SpeG-mediated polyamine-resistance provides a major fitness advantage to
USA300 during SSTI. Staphylocidal polyamine levels steadily increase within S. aureus
abscesses during the anti-inflammatory phase, peaking at day 12 (Figure 3C). To ascertain
whether the ΔspeG persistence defect resulted directly from host polyamines, we
administered a potent inhibitor of ODC, difluoromethylornithine (DFMO, Figure 2A)
(Sunkara and Rosenberger, 1987). DFMO-administration inhibited host synthesis of Spm
and Spd (Figure 3C) and completely reversed the attenuation of ΔspeG (Figure 3B). Not
only did DFMO-treatment abolish the differences between WT and ΔspeG viability, but
abscesses in treated mice exhibited fifty-fold higher organism burdens compared to
untreated animals. DFMO-treatment is known to alter the host immune response since
intracellular polyamines can limit macrophage activation and iNOS expression (Baydoun
and Morgan, 1998; Zhang et al., 2000). Thus, interfering with polyamine production leads to
dysregulation of inflammation and wound healing. Indeed, by day 12 abscesses are normally
highly structured, compact and surrounded by a meshwork of leukocytes and matrix proteins
including collagen (Figures 3D and S2). In contrast, day 12 abscesses in DFMO treated mice
are still highly disordered, lack typical ARG-1 or ODC signatures and exhibit robust iNOS
expression with virtually no detectible collagen deposition.
Host polyamine production was also essential for controlling S. aureus sepsis in that DFMO
treatment resulted in significantly higher mortality (Figure 4A). However, DFMO-treatment
was detrimental to mice infected with both Spm-resistant USA300 as well as Spm-sensitive
strain Newman. Moreover, isogenic polyamine-sensitive USA300 mutants (ΔACME and
ΔspeG) were not attenuated in a sepsis model (Figure 4B). These data imply that during
sepsis, the anti-inflammatory aspects of polyamines are essential for controlling
inflammation and tissue damage, however polyamines do not exert direct S. aureus killing.
Consistent with this finding, infected organ tissue have significantly lower amounts of all
three polyamine species when compared to infected skin (Figure 4C). Our data show that the
benefit of ACME-encoded SpeG is particularly observable during skin infections where
polyamine production is robust.
ACME-Arc drives excess host polyamine synthesis necessitating SpeG
The lack of ΔACME attenuation compared with that of ΔspeG in SSTIs presents a paradox
given that ΔspeG and ΔACME are equally susceptible to polyamines (Figure S3A)(Joshi et
al., 2011; Montgomery et al., 2009). We reasoned that ACME-Arc could divert tissue
arginine from iNOS, toward polyamine production thereby necessitating SpeG (Figures 1A
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and 2A). Accordingly, additional inactivation of the ACME-Arc system in the ΔspeG
background restored virulence, essentially phenocopying a ΔACME mutant (Figure S3A).
Moreover, the presence of Arc in USA300 directly affected tissue polyamine levels. Day 12
abscesses that were significantly infected with ACME-Arc positive strains had ~50% more
Put than abscesses infected with Arc-null mutants (Figure S3B). Furthermore, iNOS was
less abundant in abscesses infected with Arc-positive USA300 (Figure S3C). This is
consistent with lower tissue arginine levels in Arc-positive abscesses since iNOS expression
is positively regulated by the availability of arginine (Chaturvedi et al., 2007). Collectively,
these data show that ACME-Arc successfully competes with host iNOS for available
arginine and subsequently drives excessive host polyamine synthesis thereby necessitating
SpeG.
Discussion
Skin acidity stems from lactic acid in sweat and protonated organic acids can permeate
bacterial membranes to exert intracellular acid stress (Gantwerker and Hom, 2012; Harvey
et al., 2010). The ability to generate ammonia via the Arc system would greatly serve to
balance intracellular pH in this environment (Figure 1A). However, the chromosomal Arc
system of S. aureus is only active during anaerobic growth (Sun et al., 2012). The skin
surface is sufficiently aerated, thus the core Arc system is not sufficient for surviving lactic
acid stress (Figure 1B). In contrast, the ACME-Arc system is robustly expressed
independently of glucose or oxygen and therefore provides acid tolerance in aerated
environments. The mechanism by which constitutive ACME-Arc gene expression evolved is
still unknown, but clearly, ACME-Arc provides an enormous advantage to USA300 when
cultivated in an environment replete with organic acids abundant on human skin (Figure S1).
It has been further postulated that ACME-Arc may compete with iNOS for available
arginine thereby limiting the amount of NO· produced in response to USA300 infection
(Diep et al., 2006). Indeed, ACME-positive infections exhibited noticeably less iNOS
staining at day 12 when compared to ACME-negative infections (Figure S3C). However, S.
aureus is inherently resistant to NO· (Hochgrafe et al., 2008; Richardson et al., 2008) and
iNOS-deficiency did not significantly affect the outcome of S. aureus SSTIs (Figure S4A).
Even strains lacking the S. aureus flavohemoprotein (Δhmp), which exhibit increased NO·-
sensitivity were only modestly attenuated in the skin abscess model (Figure S4).
Furthermore, combining the Δhmp and ΔarcA (ACME) in USA300 did not result in
synergistic attenuation implying that NO· is not abundant enough to drastically affect the
outcome of S. aureus SSTI (Figure S4A). In contrast, iNOS has a dramatic effect on NO·-
sensitive S. epidermidis during skin infection in that S. epidermidis could replicate to the
same level as S. aureus in iNOS-deficient mice. Given that USA300 ACME was acquired
from S. epidermidis (Diep et al., 2006; Goering et al., 2007; Miragaia et al., 2009), this
island may have originally evolved to protect S. epidermidis from host NO·. However, S.
aureus must maintain ACME for reasons other than allowing this intrinsically resistant
organism to minimize NO·-exposure.
In the diseased state of a skin abscess, constitutive ACME-Arc drives host polyamine
synthesis thereby necessitating SpeG-mediated polyamine detoxification (Figures S3 and 3).
Polyamine synthesis is more robust in actively dividing cells (Cohen, 2000). The skin is an
organ constantly undergoing regeneration and consequently, polyamine levels are reportedly
higher in the lower strata of the epidermis than in most other organ sites (Baze et al., 1985).
Moreover, during the wound-healing phase of a SSTI, multiple cell types are rapidly
expanding creating a heightened polyamine requirement. Accordingly, polyamines are more
than twice as abundant within day 12 abscesses than in resting skin (Figure 3C) and
significantly more concentrated in healing skin than in infected internal organs (Figure 4C).
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The generation of ornithine by strains expressing a constitutive ACME-Arc would provide
for greater polyamine production in proliferating tissue (Figure 2A). Indeed, ACME-Arc
expression results in a 50% increase in day 12 tissue Put when the abscess is still highly
infected such that bacteria are numerous enough to exert measurable effects on host arginine
metabolism (Figure S2B). Moreover, deletion of ΔspeG alone significantly affected
persistence, however eliminating ACME-Arc reverses the ΔspeG phenotype (Figure S2A).
This implies that the excess ornithine generated by constitutive ACME-Arc pushes
polyamine levels to a point that requires SpeG-mediated detoxification. Taken together,
these observations can explain the success of USA300 in the skin environment as it can
persist in the presence of excess organic acids and polyamines. Accordingly, USA300
isolates are more commonly isolated from extranasal site than any other lineage (Miko et al.,
2012; Schechter-Perkins et al., 2011).
Inhibiting de novo polyamine synthesis completely reversed the ΔspeG phenotype (Figure
3B), despite the fact that DFMO treatment merely lowered Spm and Spd levels by ~50%
(Figure 3C). The residual polyamine content of tissue from DFMO treated mice results from
catabolism of dietary polyamines (Sunkara and Rosenberger, 1987). However, the observed
drop in polyamine levels had drastic effects on S. aureus SSTI outcomes rendering the
ΔspeG mutant indistinguishable from WT USA300 (Figure 3B). Additionally, without de
novo polyamine synthesis, the host response to S. aureus infection is significantly altered.
DFMO treated mice exhibit no measurable fibrosis and wounds are still open, inflamed and
highly infected at day 12 (Figures 3D, 3B and S1). Thus, not only do polyamines exert direct
anti-staphylococcal effects during the resolution of SSTIs, but also they are essential for
coordinating the host post-inflammatory healing response.
The contribution of ACME to virulence has been dismissed given the lack of virulence
phenotypes associated with ΔACME strains (Montgomery et al., 2009). However, the
functional modularity of ACME masks its direct role in USA300 persistence in the acidic
skin environment and within healing abscesses. We contend that the success of USA300
stems from enhanced virulence factor production combined with increased fitness that
accompanied the acquisition of the modular ACME island.
Materials and Methods
Bacterial Strains and Growth Conditions
Strains are listed in Table S1. Bacteria were grown in brain heart infusion (BHI), Tryptic soy
Broth (TSB) or in chemically defined medium (PN) (Fuller, 2011) with or without 4 mM
Arginine and 50 mM lactic acid buffered to pH 5.0. Growth was monitored by plating for
viable cfu after 24 h of aerobic incubation at 37° C and comparing viable cfu to the
inoculum (~1 × 106 cfu). Isogenic S. aureus Δarc (ACME copy) mutants were constructed
by amplifying ~1 kb 5′ and 3′ homology fragments using primers listed in Table S1. The
resulting fragments were cloned on either side of the Spr cassette in the E. coli/S. aureus
shuttle vector pBTSts (Table S1). SF8300 Δhmp strains were constructed using pTR040
(Table S1). Allelic exchange was performed as previously described (Fuller, 2011).
Animal Studies
C57BL/6J mice and isogenic iNOS−/− mice were obtained from Jackson Labs (Bar Harbor,
ME, USA). Subcutaneous infections were performed as previously described (Thurlow et
al., 2011). Briefly, mice were anesthetized with 2,2-tribromoethanol, shaved, and injected
with 20 μl of PBS containing 1 × 108 CFU of bacteria. DFMO was administered at 1%
wt:vol in water one day prior to inoculation and continuing throughout infection. Mice were
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euthanized and abscesses were collected to determine bacterial burdens and polyamine
content on days 3, 7, and 12 post-inoculation.
For sepsis studies, mice were infected by tail vein injection with 5 × 106 CFU of bacteria.
Mouse weights were monitored daily and mice were euthanized once 30% of their initial
body weight was lost as per IACUC approved protocol.
Immunofluorescence staining
Immunohistochemistry on tissue was performed as previously described (Thurlow et al.,
2011). Abscess tissue was fixed in 10% formalin, paraffin embedded, sectioned (10 μm),
and H&E stained by the UNC Histopathology Core Facility. Unstained sections were
deparaffinized using a graded series of xylene and ethanol washes followed by microwaving
for 20 min in 10 mM sodium citrate buffer (pH 6) for antigen retrieval. Specimens were
blocked in 10% donkey serum (Jackson ImmunoResearch, West Grove, PA, USA) and
subsequently stained with antibodies specific for iNOS (Abcam, Cambridge, MA, USA),
ARG-1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), Type 1 Collagen (Abcam), or
ODC (US Biological, Swampscott, MA USA). Staining was detected using biotinylated
secondary antibodies followed by streptavidin-DyLight™-594 or -488 conjugates (Jackson
ImmunoResearch). Stained sections were mounted in Pro-Long Gold with DAPI
(Invitrogen, Grand Island, NY, USA) and viewed using an Olympus BX60 fluorescence
microscope. iVision software v. 4.0.0 (BioVision Technologies) was used for image
collection.
Quantitative Real-Time Reverse-Transcriptase PCR (Q RT-PCR)
RNA was harvested as previously described (Richardson et al., 2006) from mid-exponential
cultures (OD660 = 0.5) cultivated anaerobically in TSB lacking glucose and supplemented
with 50 mM arginine. Alternatively, similarly grown cultures were supplemented with
glucose (25mM) or cultured aerobically in its absence. Q RT-PCR was performed on 50 ng
of total RNA using a My-iQ Thermocycler (BioRad, Indianapolis, IN) as previously
described (Joshi et al., 2011).
Determination of Tissue Polyamine Content
TCA-soluble fractions of tissue homogenates (500 μg total protein equivalent) were
neutralized with Na2CO3 and mixed with 200 μl fluorescamine (2 mg/ml in acetonitrile)
combined with 150 μl Borate buffer (pH 8.0, 0.1M). The samples were incubated at room
temperature for 10 min followed by chloroform extraction. The aqueous phase was washed
with 6 ml of 15% MeOH on a Waters Sepak C-18 column, eluted with 1 ml of 100% MeOH
and evaporated to 250 μl at 60° C. 100 μl of the eluate was combined with 150 μl H2O and
injected via Waters™ 717plus Autosampler into an Applied Biosystems 140B solvent
delivery system and separated on a Waters SunFire™ C18 5 μm 2.1×150 mm column.
Separation was achieved using a 0.1% TFA:MeOH gradient at 100 μl/min flow as follows:
15% MeOH for 4min then to 50% MeOH by 5 min. Gradient from 50% to 68% over 10
min, then to 70% in 1 minute. Finally, gradient from 70% to 100% in 10 minutes.
Fluorescamine derivatized polyamines were detected via a Hewlett Packard 1046A
programmable fluorescent detector (Ex = 405 nm, Em = 485 nm) and polyamine
concentrations were quantified by comparing to known standards. Values were analyzed
with a Peaksimple Chromatography Data System (SRI, Torrance, CA).
Flow Cytometry
Harvested tissues were strained through a 70 μm mesh filter then treated with type-1
collagenase and DNase (Worthington Biochem Corp., Lakewood, NJ). Cells were washed
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then incubated with Fc Block (BD Biosciences). The antibodies used were anti-CD45-efluor
450 (eBiosciences, 30-f11), anit-CD11b-APC (eBio, M1/70), anti-GR1-PEcy7 (Biolegend,
RB68C5), anti-CD3-FITC (BD Pharmagen, 145 2c11), anti-B220-FITC (BD, RA3-6B2),
anti-iNOS-PE (Santa Cruz, polyclonal), sheep anti-Arginase-1 (R&D systems), and donkey
anti-sheep-PE (R&D). Intracellular staining of iNOS and Arg-1 was performed as
previously described (Neely et al., 2011). Live cells were scored using pacific orange
conjugated succinimidyl ester. Data were collected using a FACS Cyan (Dako, Ft. Collins,
CO) and analyzed using Summit software (Dako, Ft. Collins, CO). Graphs represent the
percentage iNOS or Arginase-1 producing live cells that were CD45+ CD11b+, GR-1Lo-Int,
and CD3−, B220−.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• USA300 ACME Arginine-deiminase system (ARC) allows S.aureus growth in
acidic environments
• ACME-Arc drives excess host polyamine synthesis, which is toxic to S. aureus
• ACME-encoded polyamine-resistance enzyme SpeG is essential for combating
excess polyamines
• Inhibiting host polyamine production restores ΔspeG persistence and affects
wound healing
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Figure 1. Constitutive USA300 ACME-Arc provides resistance to skin-like acidity
A. Arc system of S. aureus converts extracellular arginine to ornithine while producing ATP
and ammonia. B. Growth of ACME-postive and –negative (grey bars) S. aureus in defined
media replete with arginine and acidified (pH 5.0) with lactic acid. See also (Figure S1). C.
Quantitative RT-PCR showing constitutive expression of ACME-arcA relative to
chromosomal-arcA.
Thurlow et al. Page 13













Figure 2. The fate of host arginine during USA300 S. aureus skin infections
A. Arginine metabolism in response to cytokines during skin infections. B. Dermonecrotic
lesion 3 days after subcutaneous inoculation with 1 × 108 cfu of USA300 S. aureus. C.
Viable cfu/abscess over time from mice infected with WT USA300 S. aureus, Methicillin-
sensitive S. aureus Newman (MSSA), S. epidermidis RP62a or E. faecalis V583. S.
epidermidis and E. faecalis abscesses harbored significantly fewer viable cfu compared with
USA300 at all three timepoints whereas S. aureus strain Newman was significantly
attenuated compared with USA300 at days 7 and 12 (p ≤ 0.05 Mann-Whitney). D.
Representative H&E stained tissue imaged at 4× magnification from an infected lesion 3, 7
and 12 dpi. E. Immunofluorescent staining of tissue imaged at 20× from an infected lesion
3, 7 and 12 dpi using α-iNOS antibodies and counterstained with DAPI. F. Similar to Figure
1E except using α-Arg-1 primary antibodies. G. Results of flow cytometery on extracted
abscess tissue from day 7 and 12 murine SSTIs. Cells were gated on the living macrophage-
like cell population (CD45Hi CD11bHi GR-1Lo-Int CD3Lo B220Lo) and counted for
intracellular staining with either anti-Arg-1 or anti-iNOS antibodies.
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Figure 3. USA300 polyamine-resistance is essential for persistence during the post-inflammatory
wound healing response
A. Viable cfu per abscess of WT USA300 and isogenic ΔspeG at 3, 7 and 12 dpi.
Significance was assessed via Mann-Whitney. B. Viability of WT USA300 clones (SF8300
(SF) and LAC) and isogenic ΔspeG mutants in 12-day abscesses. Repaired ΔspeG (SF
ΔspeG∷speG) is fully virulent. DFMO treatment abrogates ΔspeG attenuation. C.
Increasing polyamine levels (nmol/mg tissue) detected in S. aureus abscesses throughout the
infection. (*) significantly higher levels compared with day 0. ($) significantly reduced
levels in tissue from DFMO treated animals (p< 0.05 Man-Whitney). D. Immunofluorescent
staining of day 12 abscesses imaged at 20× magnification from mice treated with/without
DFMO using indicated antibodies and counterstained with DAPI.
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Figure 4. Polyamines are critical during sepsis, but levels are not sufficient to directly kill S.
aureus
A. Survival of eight 4–6 week female C57BL/6 mice (treated or untreated with DFMO)
following i.v. inoculation with 5 × 106 cfu of USA300 S. aureus or MSSA strain Newman.
DFMO treatment significantly exacerbated disease outcomes for both USA300 and Newman
infections (p < 0.05, Kaplan Meier). B. Weight loss following i.v. inoculation of 8 mice with
5 × 106 cfu of WT USA300 and isogenic ΔACME or ΔspeG mutants. C. Organ tissue
polyamines levels detected 7 days after infection when mice begin to resume weight gain
compared with levels found in resolving S. aureus abscesses.
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